Barbara A. Bopp

Metabolism and disposition of clarithromycin in man.

J L Ferrero, Barbara A. Bopp, Kennan C. Marsh et al. · Drug Metabolism and Disposition · 1990 · 136 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +8

Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency

Jay R. Luly, Nwe Y. BaMaung, Jeff Soderquist et al. · Journal of Medicinal Chemistry · 1988 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability

Jacob J. Plattner, Patrick A. Marcotte, Hollis D. Kleinert et al. · Journal of Medicinal Chemistry · 1988 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Stereoselective pharmacokinetics of pazinaclone, a new non‐benzodiazepine anxiolytic, and its active metabolite in healthy subjects

Ziad Hussein, Darcy J. Mulford, Barbara A. Bopp et al. · British Journal of Clinical Pharmacology · 1993 · 43 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement

Joseph F. Dellaria, Robert G. Maki, Barbara A. Bopp et al. · Journal of Medicinal Chemistry · 1987 · 34 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14